#-supreme-cellcarta-differentiators-5-450{items-data:[{"text":"Deep Scientific Rigor"},{"text":"Integrated Multi-Modal Capabilities"},{"text":"Global Execution"},{"text":"Complex Biomarker Expertise"},{"text":"High-Touch Collaboration"}]}#-supreme-cellcarta-overview-3-450{stats-data:[{"number":"25+","label":"Years of expertise"},{"number":"8","label":"Global facilities"},{"number":"750+","label":"Employees"}]}#-supreme-cellcarta-service-cards-4-450{cards-data:[{"image":"https://cellcarta.supremeclients.com/wp-content/uploads/2026/07/21-Biomarker-Solutions-Hero.jpg","image_alt":"CellCarta scientist developing multi-platform biomarker strategies across discovery and clinical development stages","title":"Biomarker Solutions","description":"Multi-platform biomarker strategies from discovery through clinical development.","link1_label":"","link1_url":"","link2_label":"","link2_url":"","link3_label":"","link3_url":"","link4_label":"","link4_url":"","link5_label":"","link5_url":"","card_link_url":"/capabilities/biomarkers/"},{"image":"https://cellcarta.supremeclients.com/wp-content/uploads/2026/06/Genomics-Services-449.jpg","image_alt":"Genomics laboratory scientist performing molecular platform analysis on clinical samples for biomarker reporting","title":"Genomics","description":"Proven and emerging molecular platforms for clinical sample analysis and reporting.","link1_label":"Sequencing Services","link1_url":"/capabilities/genomics/sequencing-services/","link2_label":"Digital PCR (dPCR)","link2_url":"/capabilities/genomics/digital-pcr-services/","link3_label":"Quantitative PCR (qPCR)","link3_url":"/capabilities/genomics/qpcr-services/","link4_label":"Assays by Mutations","link4_url":"/capabilities/genomics/assays-by-mutations/","link5_label":"","link5_url":"","card_link_url":"/capabilities/genomics/"},{"image":"https://cellcarta.supremeclients.com/wp-content/uploads/2026/07/Histopathology-Services-hero-34.jpg","image_alt":"Histopathologist performing multiplexed tissue analysis with AI-powered image analysis at CellCarta","title":"Histopathology","description":"Multiplexed tissue analysis with in-house pathologists and AI-powered image analysis.","link1_label":"Digital Pathology","link1_url":"/capabilities/histopathology/digital-pathology/","link2_label":"IF and IHC","link2_url":"/capabilities/histopathology/if-ihc/","link3_label":"ISH","link3_url":"/capabilities/histopathology/ish/","link4_label":"Spatial Biology","link4_url":"/capabilities/histopathology/spatial-biology/","link5_label":"","link5_url":"","card_link_url":"/capabilities/histopathology/"},{"image":"https://cellcarta.supremeclients.com/wp-content/uploads/2026/06/19-IImmune-Monitoring-hero.jpg","image_alt":"Scientist conducting multiplex immune response monitoring assays supporting clinical trial biomarker programs","title":"Immune Monitoring","description":"Multiplex assays for immune response monitoring across all clinical trial phases.","link1_label":"Basophil Activation Test (BAT)","link1_url":"/capabilities/immune-monitoring/basophil-activation-test/","link2_label":"Cell Enumeration","link2_url":"/capabilities/immune-monitoring/cell-enumeration/","link3_label":"Cell Proliferation","link3_url":"/capabilities/immune-monitoring/cell-proliferation-assays/","link4_label":"Cellular Phenotyping","link4_url":"/capabilities/immune-monitoring/cell-phenotyping/","link5_label":"","link5_url":"","card_link_url":"/capabilities/immune-monitoring/"},{"image":"https://cellcarta.supremeclients.com/wp-content/uploads/2026/06/Immunoassay-Services-hero-9.jpg","image_alt":"CellCarta scientist operating validated immunoassay platforms for precise biomarker quantification and clinical testing","title":"Immunoassay Platform","description":"Validated immunoassay platforms for precise biomarker quantification and clinical testing.","link1_label":"Ella™","link1_url":"/capabilities/immunoassay-services/ella-multiplexing-elisa/","link2_label":"Olink PEA","link2_url":"/capabilities/immunoassay-services/olink-pea-technology/","link3_label":"FluoroSpot and ELIspot","link3_url":"/capabilities/immunoassay-services/fluorospot-elispot/","link4_label":"Hybrid LBA/LC-MS","link4_url":"/capabilities/immunoassay-services/hybrid-lba-lc-ms/","link5_label":"","link5_url":"","card_link_url":"/capabilities/immunoassay-services/"},{"image":"https://cellcarta.supremeclients.com/wp-content/uploads/2026/07/Proteomics-Services-Hero-36.jpg","image_alt":"Mass spectrometry scientist running fully integrated MS platforms for large-scale discovery and bioanalytical testing","title":"Proteomics","description":"Fully integrated MS platforms for large-scale discovery and bioanalytical testing.","link1_label":"Unbiased Discovery","link1_url":"/capabilities/proteomics/unbiased-discovery/","link2_label":"Biomarker Quantification","link2_url":"/capabilities/proteomics/biomarker-quantification/","link3_label":"","link3_url":"","link4_label":"","link4_url":"","link5_label":"","link5_url":"","card_link_url":"/capabilities/proteomics/"}]}#-supreme-cellcarta-testimonials-6-450{items-data:[{"image":"","image_alt":"","quote":"Your RNAseq services are best in class and delivered lower duplication rates and much better unique read coverage.","author_name":"Biopharma Partner","author_role":"","author_company":""},{"image":"","image_alt":"","quote":"I turn to CellCarta for my most challenging samples and assay needs. Their mass spec team has a strong reputation for delivering robust,reliable data on tight timelines using advanced technologies for difficult analytical challenges.","author_name":"Biopharma Partner","author_role":"","author_company":""}]}